Article
Extremely potent Human Monoclonal Antibodies for the Prophylaxis and Therapy of Tetanus
bioRxiv · 2021 · Marco Pirazzini
Key facts
| Title | Extremely potent Human Monoclonal Antibodies for the Prophylaxis and Therapy of Tetanus |
|---|---|
| First author | Marco Pirazzini |
| Journal | bioRxiv |
| Published | May 25, 2021 |
| DOI | 10.1101/2021.05.24.445390 |
| Devices mentioned | BK110039, K042152, K051299, K092450, K100706, K103085, K103302, K103414, K110783, K120063, K120270, K121096 and 8 more |
| Product codes mentioned | CFN, CFQ, CZJ, CZP, DFZ, JIT, LIQ, MAX, MNH, MNI, NDS, NKB and 6 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1